75 related articles for article (PubMed ID: 9207252)
41. [Molecular biology in the development of colorectal cancer].
Nagawa H; Muto T
Gan To Kagaku Ryoho; 1999 Dec; 26(14):2147-53. PubMed ID: 10635297
[TBL] [Abstract][Full Text] [Related]
42. [Colorectal cancers].
Miyoshi Y; Nakamura Y
Tanpakushitsu Kakusan Koso; 1997 Jul; 42(10 Suppl):1723-31. PubMed ID: 9279105
[No Abstract] [Full Text] [Related]
43. Deleted in colorectal cancer protein expression as a possible predictor of response to adjuvant chemotherapy in colorectal cancer patients.
Gal R; Sadikov E; Sulkes J; Klein B; Koren R
Dis Colon Rectum; 2004 Jul; 47(7):1216-24. PubMed ID: 15148649
[TBL] [Abstract][Full Text] [Related]
44. Status of deleted in colorectal cancer gene expression correlates with neuroblastoma metastasis.
Reyes-Mugica M; Lin P; Yokota J; Reale MA
Lab Invest; 1998 Jun; 78(6):669-75. PubMed ID: 9645757
[TBL] [Abstract][Full Text] [Related]
45. Opposing roles of netrin-1 and the dependence receptor DCC in cancer cell invasion, tumor growth and metastasis.
Rodrigues S; De Wever O; Bruyneel E; Rooney RJ; Gespach C
Oncogene; 2007 Aug; 26(38):5615-25. PubMed ID: 17334389
[TBL] [Abstract][Full Text] [Related]
46. DCC: a tumor suppressor gene expressed on the cell surface.
Hedrick L; Cho KR; Boyd J; Risinger J; Vogelstein B
Cold Spring Harb Symp Quant Biol; 1992; 57():345-51. PubMed ID: 1339669
[No Abstract] [Full Text] [Related]
47. DCC: linking tumor suppressor genes and altered cell surface interactions in cancer?
Cho KR; Fearon ER
Curr Opin Genet Dev; 1995 Feb; 5(1):72-8. PubMed ID: 7749329
[TBL] [Abstract][Full Text] [Related]
48. Mediation of the DCC apoptotic signal by DIP13 alpha.
Liu J; Yao F; Wu R; Morgan M; Thorburn A; Finley RL; Chen YQ
J Biol Chem; 2002 Jul; 277(29):26281-5. PubMed ID: 12011067
[TBL] [Abstract][Full Text] [Related]
49. Should DCC be deleted as tumor-suppressor candidate?
Gastroenterology; 1997 Jul; 113(1):3. PubMed ID: 9207252
[No Abstract] [Full Text] [Related]
50. DCC and SMAD4 alterations in human colorectal and pancreatic tumor dissemination.
Tarafa G; Villanueva A; Farré L; Rodríguez J; Musulén E; Reyes G; Seminago R; Olmedo E; Paules AB; Peinado MA; Bachs O; Capellá G
Oncogene; 2000 Jan; 19(4):546-55. PubMed ID: 10698524
[TBL] [Abstract][Full Text] [Related]
51. Homozygous deletions inactivate DCC, but not MADH4/DPC4/SMAD4, in a subset of pancreatic and biliary cancers.
Hilgers W; Song JJ; Haye M; Hruban RR; Kern SE; Fearon ER
Genes Chromosomes Cancer; 2000 Apr; 27(4):353-7. PubMed ID: 10719364
[TBL] [Abstract][Full Text] [Related]
52. Evaluation of genetic mutations of tumor suppresser genes in colorectal cancer patients.
Kubo H; Miki C; Kusunoki M
Hepatogastroenterology; 2004; 51(55):114-7. PubMed ID: 15011843
[TBL] [Abstract][Full Text] [Related]
53. [DCC changes and prognosis in colorectal carcinoma].
Fiocca R
Pathologica; 1998 Feb; 90(1):79-80. PubMed ID: 9628983
[No Abstract] [Full Text] [Related]
54. Role of the dependence receptor DCC in colorectal cancer pathogenesis.
Mehlen P; Fearon ER
J Clin Oncol; 2004 Aug; 22(16):3420-8. PubMed ID: 15310786
[TBL] [Abstract][Full Text] [Related]
55.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
56.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
